
Following the October 2026 introduction of EVErECM and EVE ARI, the South Korean company expands its professional aesthetic portfolio with lab-grown organoid ECM and multi-peptide formulations. SEOUL, South Korea, Nov. 6, 2026 /PRNewswire-PRWeb/ — Growing interest in advanced skin…


